Topics
Glioma | Outcomes | Overall survival
Home > Publications > Topics > Glioma > Outcomes > Overall survival
Falcão L, Cerqueira GA, Gonçalves JPF, de Andrade
JFT, de Azevedo Figueiredo Trocoli CP, Medrado-Nunes GS, Santos
VEC, Pustilnik HN, Fontes JHM, Dos Passos GS.
Influence
of supratotal resection on overall survival and progression of
tumor in gliomas grade 2 and 3: a systematic review and
meta-analysis.
Neurosurg
Rev. 2025 Mar 4;48(1):281. doi:
10.1007/s10143-025-03428-x. PMID:
40032671. Review; Meta-analysis˰
ˍ
Li D, Chen Y, Wong TF, Yang Q, Guo C, Jiang X, Ke C, Zhang X, Zeng
J, Lv Y, Wu S, Wang J, Sai K, Mou Y, Chen Z.
Management
and survival trends for diffuse gliomas diagnosed at a single
neurooncology center in China during 2000 to 2020.
Sci
Rep. 2025 Apr 12;15(1):12574. doi:
10.1038/s41598-025-95693-5. PMID:
40221458. Observational study. ˍ
Carriere PP, Haisraely O, Aaroe A, Ahmed K, Lewis R, Colson-Fearon
D, Bolden M, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom
MC, Li J, McGovern S, McAleer MF, Ghia A, Jiang W, Chung C,
Grosshans D, Ballester L, Esquenazi Y, Kamiya-Matsuoka C, Yeboa
DN.
Long-term outcomes in IDH-wildtype
(IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
J
Neurooncol. 2026 Jul 23;179(1):12. doi:
10.1007/s11060-026-05712-2. PMID:
42489814. ˍ